Skip to main content

Yukon Supports The Riverside Company’s Investment in Western Botanicals

Yukon Partners (“Yukon”), a provider of junior capital for middle market private equity transactions, is pleased to announce it has partnered with The Riverside Company (“Riverside”) to support its investment in Western Botanicals (the “Company”).

Western Botanicals is a premier, full-service nutraceutical contract development and manufacturing organization serving more than 75 health and wellness brands across a diversified range of end use applications. With nearly three decades of experience, the Company offers end-to-end formulation, manufacturing, and packaging solutions across capsule, powder, and liquid formats from its 140,000+ square feet of FDA-registered, cGMP compliant facilities with organic and NSF-certifications. Western Botanicals combines deep industry expertise with a solutions-oriented, customer-centric culture, delivering products rooted in innovation, quality, and efficacy.

“We are excited to partner with the management team to build on the Company’s strong momentum,” said Brad Roberts, Co-Chief Investment Officer of Riverside’s Capital Appreciation strategy. “Together, we aim to support continued organic growth, expand product and format capabilities, and further establish Western Botanicals as a comprehensive solution for its customers.”

“We strive to partner with industry-leading nutraceutical brands through unmatched service, transparency, and quality,” said Western Botanicals CEO Don Shaver. “Our partnership with Riverside will allow us to continue this mission through organic growth while simultaneously executing an M&A strategy to build best-in-class capabilities.”

“The Company’s full-service capabilities, diversification, and well-invested facilities position Western Botanicals to continue driving strong growth,” said Dave Sampair, a Partner at Yukon. “We are excited to support the Western Botanicals team and look forward to another successful partnership with Riverside.”

Winston & Strawn LLP provided legal counsel to Yukon.

About Western Botanicals

Western Botanicals is a contract manufacturer of vitamins, minerals, and supplements, formulating, manufacturing, and packaging capsules, powders, and liquids, and serving a diversified base of 75+ customers with a focus on digitally-native consumer health and wellness brands. The Company manufactures 500+ SKUs supporting a variety of end use applications. Western Botanicals is headquartered in Spanish Fork, Utah, and operates three facilities with 140,000+ square feet of total capacity.

About Yukon Partners

Yukon Partners is an independent and unaffiliated junior capital provider, primarily serving middle market private equity sponsor led business transactions in the U.S. and Canada. The transactions in which Yukon invests include buyouts, growth and platform strategies, recapitalizations, mergers/acquisitions, and public-to-private buyouts. Yukon typically invests up to $75 million per transaction and currently manages $2.6 billion across five funds. Yukon Partners has offices in Minneapolis, Boston, and West Palm Beach. For more information, please visit www.yukonpartners.com.

About The Riverside Company

The Riverside Company is a global investment firm focused on being one of the leading private equity and flexible capital options for business owners and portfolio company employees at the smaller end of the middle market by seeking to fuel transformative growth and create lasting value. Since its founding in 1988, Riverside has made more than 1,100 investments. The firm’s international private equity and flexible capital portfolios include more than 140 companies. For more information, visit www.riversidecompany.com.

"We are excited to support the Western Botanicals team and look forward to another successful partnership with Riverside." - Dave Sampair

Contacts

Dave Sampair
Partner
Yukon Partners
612-435-7814

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.22
+1.95 (0.95%)
AAPL  273.68
+7.50 (2.82%)
AMD  211.42
+14.82 (7.54%)
BAC  49.89
-1.18 (-2.31%)
GOOG  307.75
-3.94 (-1.26%)
META  634.48
-2.77 (-0.43%)
MSFT  387.49
+3.02 (0.79%)
NVDA  191.29
-0.26 (-0.14%)
ORCL  145.79
+4.48 (3.17%)
TSLA  405.04
+5.21 (1.30%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.